Close Menu

Health Sciences In The Media

  • Immunity against COVID-19 may persist for at least five months after being infected with the SARS-CoV-2 virus, according to a study led by an Indian-origin researcher in the US. The researchers from the University of Arizona Health Sciences studied the production of antibodies from a sample of nearly 6,000 people infected with the novel coronavirus. 

  • As the price tag of cyberattacks on healthcare continues to rise, radiology looks to bolster its defenses. “Not a week goes by that you don’t hear about a hospital system that’s been impacted by a malicious software attack,” said James Whitfill, M.D., chief transformation officer and vice president of Honor Health and clinical associate professor of internal medicine and bioinformatics at the University of Arizona College of Medicine. “Our radiology departments and practices, in general, need to have a heightened sense of awareness.”

  • To pay tribute to the contributions of its honorees, the Mel and Enid Zuckerman College of Public Health at the University of Arizona will be holding “The 20 Days for 20 Years” celebration.

  • A study by researchers from the University of Arizona Health Sciences published in the journal Pain showed that the SARS-CoV-2 virus, which is the virus causing COV-19, has the ability to relieve pain. This finding may explain why almost half of the people who get infected with COVID-19 experience only a few symptoms or no symptoms at all. However, the lack of symptoms does not make them less contagious because they can still spread the virus.

  • Continuing coverage: Q&A with Environmental microbiologists and public health researchers at the University of Arizona: Kelly Reynolds, professor and chair of the Community, Environment and Policy Department at the Mel and Enid Zuckerman College of Public Health and Charles Gerba, an environmental microbiologist from the College of Agriculture and Life Sciences.

  • The number of new COVID-19 cases in Pima County has fallen in recent weeks from a high in mid-September. “Things aren’t too bad,” said Dr. Joe Gerald, an associate professor with the University of Arizona’s Zuckerman College of Public Health. “Our hospitals aren’t overwhelmed. Case counts are kind of low. It’s this very weird place where complacency is our biggest enemy right now. While we’re doing well in the moment, we’re not that far away from being back in some of those situations that we faced back in June.”

  • WIRED - Oct. 10

    Through a National Institutes of Health program called “All of Us,” tribal nations across Indian Country are pushing federal scientists to conduct disease research that serves Indigenous peoples in a meaningful way. “We’re concerned about access to data as well as release of data without tribal permission,” said Stephanie Russo Carroll, a professor in the University of Arizona's Mel and Enid Zuckerman College of Public Health. “What the pandemic has shed a light on is the need for tribes to have access to external data.”

  • More nightclubs in Scottsdale reopened this weekend after being shut down for reportedly violating COVID-19 guidelines. Dr. Shad Marvasti, director of public health, prevention and health promotion with the University of Arizona College of Medicine – Phoenix, said regulation will be crucial. Even with guidelines in place, he said it is important to know the risks. "Any event that you do, with or without the mask, if you do something indoors versus outdoors, there is six times the increased likelihood of spreading it or getting it," Marvasti said.

  • As more than 200,000 Americans have died from COVID-19, cancer patients – who are often immunocompromised and depend on regular treatments to prevent the progression of the disease – are particularly at risk for dying by the potentially deadly virus. "Most cancers themselves put patients into immune-compromised states. That state is profoundly reinforced and worsened by the treatments that we give," said Dr. Julie Bauman, deputy director of the University of Arizona Cancer Center.

  • Daniel Latt, MD/PhD, associate professor and orthopaedic surgeon at the University of Arizona College of Medicine – Tucson and Naohiro Shibuya, DPM, from Texas A&M College of Medicine, are working with MedShape Inc. on research and development of a compression fusion device using superelastic nickel-titanium (NiTiNOL) for use in diabetic foot limb salvage surgery. The study is funded by a Technology/Therapeutic Development Award from the U.S. Department of Defense Peer-Reviewed Medical Research Program.

  • Fox News - Oct. 8

    The virus that causes COVID-19 acts as a pain reliever, suggests the findings of a new study that could offer “one possible explanation for the unrelenting spread” of the disease, researchers said. Researchers with the University of Arizona Health Sciences said SARS-CoV-2, the virus that causes COVID-19, may inadvertently function as a pain reliever, which “may explain why nearly half of all people who get COVID-19 experience few or no symptoms, even though they are able to spread the disease.

  • The novel coronavirus may be able to block pain and mask the illness in its early stages as it spreads throughout the body, a new study suggests. The team, from the University of Arizona Health Sciences, says the findings may explain why nearly half of all patients with COVID-19 experience no symptoms.

  • The University of Arizona researchers have discovered that COVID-19 can give a false sense of pain relief. Many people with COVID-19 don’t show symptoms right away or are asymptomatic entirely, which sparked the interest of researchers at the U of A.

  • Tucson Weekly - Oct. 8

    Julie Bauman is an oncologist and the deputy director of the University of Arizona Cancer Center. As a specialist who works with cancer patients every day, she understands their unique vulnerability to COVID-19. Due to this increased risk, doctors at the UA Cancer Center noticed a decrease in patients coming in for preventive screenings at the height of the pandemic, resulting in an increase in advanced cases arriving at the cancer center as the number of coronavirus cases declines. 

  • Research from the University of Arizona Health Sciences found that people who suffer from migraines may benefit from something called green light therapy which is exactly what it sounds like.  Listeners call in to the live Dana & Parks Show and share their experience living with migraines.

  • NPR - Oct. 8

    President Donald Trump continues to tout an experimental treatment he received for COVID-19 as a cure for the disease despite an absence of evidence to back up that claim. Immunobiologist Deepta Bhattacharya at the University of Arizona College of Medicine - Tucson said there's a theoretical chance the treatment could prevent people from developing their own immunity. The monoclonal antibodies may block the part of the virus that the immune system needs to "see" to develop protective immunity. If that's the case, the immune system wouldn't develop its own longer-lasting antibodies.

  • President Trump is described as symptom-free, but experts question the significance of his antibody test results. Dr. Deepta Bhattacharya, an immunologist at the University of Arizona College of Medicine said the results shared by White House physician Dr. Sean P. Conley wouldn’t shed much light on Mr. Trump’s condition. “The way that it’s implied is that he’s made a normal immune response, but I don’t see how you would be able to tell the difference.”

  • New research from the University of Arizona Health Sciences could explain why nearly half of all people who get coronavirus show few or no symptoms.

  • Coronavirus could go on undetected for some people. As the President of America reportedly has 'no symptoms' after falling ill, scientists discover how the disease may dull the senses. In October 2020, researchers from the University of Arizona Health Sciences revealed coronavirus is capable of dulling pain pathways. The study is published in the journal Pain.

  • An international research team has found further evidence that rare gene mutations can cause cerebral palsy, findings which could lead to earlier diagnosis and new treatments for this devastating movement disorder. Michael Kruer, a neurogeneticist at Phoenix Children’s Hospital and the University of Arizona College of Medicine – Phoenix, is senior author of the study.

Pages